Free Shipping with Auto-Delivery & Savings up to 20% with a Package Plan
1 888 433 4726
30 day supply: 120 capsules VIEW DRINK MIX
PRICE: $39.95
Save up to 20% Learn more » Purchase 3-5 Bottles: Save 5% Purchase 6-11 Bottles: Save 12% Purchase 12+ Bottles: Save 20% Applies to any product combination.
Suggested Use: take a total of four capsules daily, with meals (two capsules taken orally, twice daily).
Note: pregnant or lactating women or individuals with medical conditions should consult a physician before using.
Note: MacularProtect Complete contains 80 mg of zinc, a level that was found to support eye health in the AREDS clinical trial. It is important to check with your physician prior to taking this product to ensure that this level of zinc is appropriate for you.
Following are some frequently asked questions about this product. Click on a question to view each answer.
- Close
The findings for the Age-Related Disease Study (AREDS) were released in October, 2001. The AREDS clinical trial has been heralded by doctors and nutrition experts as the most significant clinical trial on nutrition and age-related macular degeneration (AMD) ever. Findings of the 6 ½ year AREDS clinical trial, demonstrated a statistically significant reduction in the rate of progression of AMD in 3,640 patients taking a supplement containing vitamins, antioxidants and zinc.
The AREDS2 clinical trial, released in May, 2013, tested several variations of the original AREDS supplement, in addition to omega-3 fatty acids from fish oil, and lutein and zeaxanthin. Read more about the findings here. Based on the findings from AREDS2, the National Eye Institute now recommends a beta-carotene free formula (with lutein and zeaxanthin), such as MacularProtect Complete.
Some analyses of genetic data from the AREDS clinical trial have questioned the role of zinc for those with certain genetic risk factors for age-related macular degeneration. However, these findings are not supported by independent analyses of AREDS data, which found health benefits from zinc across all genetic profiles examined. Further, 3 independent biostatistics teams at top medical centers have assessed this question, and have concluded that there is no evidence for zinc increasing risk of AMD progression for those with high risk or other specific genetic profiles. Based on the totality of evidence, the American Academy of Ophthalmology has recommended against genetic testing by ophthalmologists for AMD and other complex eye diseases. SBH has consulted with top experts in the fields of genetics and nutrition and continues to monitor the evidence on this issue.
Since studies to date on this topic have relied on very limited data, and since the influence of zinc on AMD genetic risk has never been tested in a gold standard clinical trial, more research is clearly needed. The National Eye Institute continues to recommend a macular formula that includes 80 mg of zinc for those with intermediate to advanced AMD. SBH will continue to monitor the research on this topic. To view SBH's detailed response to this issue, click here.
MacularProtect is a stand-alone product based on AREDS and AREDS2 - but does not provide a multinutrient component.
MacularProtect-Complete AREDS2 is a convenient, all-in-one nutritional formulation that includes the nutrients at levels studied in the AREDS and AREDS2 clinical trials plus a complete multinutrient for whole body health.
MacularProtect-Complete AREDS2 was created in response to doctor concern that patients combining a potent AREDS formula with a separate multivitamin may be exceeding safe levels of certain nutrients, such as zinc. MacularProtect-Complete AREDS2 is carefully formulated to provide complete support for macular and whole body health while ensuring proper nutrient levels. It is also a convenient alternative to having to manage multiple nutritional products.
PRICE: $22.95
PRICE: $38.95